Effects of pH alteration on respiratory syncytial virus in human airway epithelial cells

Background Respiratory syncytial virus (RSV) is a leading cause of respiratory distress and hospitalisation in the paediatric population. Low airway surface pH impairs antimicrobial host defence and worsens airway inflammation. Inhaled Optate safely raises airway surface pH in humans and raises intracellular pH in primary human airway epithelial cells (HAECs) in vitro. We aimed to determine whether raising intracellular pH with Optate would decrease infection and replication of RSV in primary HAECs. Methods We cultured HAECs from healthy subjects in both air–liquid interface and submerged conditions. We infected HAECs with green fluorescent protein-labelled RSV (GFP-RSV; multiplicity of infection=1) and treated them with Optate or PBS control. We collected supernatant after a 4-h incubation and then every 24 h. We used fluorescence intensity, fluorescent particle counts, plaque assays, Western blots and ELISA to quantitate infection. Results In submerged culture, fluorescence intensity decreased in Optate-treated cells (48 h p=0.0174, 72 h p≤0.001). Similarly, Optate treatment resulted in decreased fluorescent particle count (48 h p=0.0178, 72 h p=0.0019) and plaque-forming units (48 h p=0.0011, 72 h p=0.0148) from cell culture supernatant. In differentiated HAECs cultured at ALI, Optate treatment decreased fluorescence intensity (p≤0.01), GFP via Western blot and ELISA (p<0.0001), and RSV-fusion protein via ELISA (p=0.001). Additionally, RSV infection decreased as Optate concentration increased in a dose-dependent manner (p<0.001). Conclusions Optate inhibits RSV infection in primary HAECs in a dose-dependent manner. These findings suggest that Optate may have potential as an inhaled therapeutic for patients with RSV. Low airway surface pH impairs antimicrobial host defence and worsens airway inflammation. A novel, inhaled, alkaline buffer medication, Optate, raises airway pH and inhibits RSV infection in primary human airway epithelial cells in a dose-dependent manner. https://bit.ly/4138MAM

[1]  S. Whelan,et al.  SARS-CoV-2 requires acidic pH to infect cells , 2022, bioRxiv.

[2]  K. Kloepfer,et al.  A Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human Subjects , 2020, Respiratory Care.

[3]  A. Curns,et al.  Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016 , 2020, Pediatrics.

[4]  P. Hardelid,et al.  β2-integrin LFA1 mediates airway damage following neutrophil transepithelial migration during respiratory syncytial virus infection , 2020, European Respiratory Journal.

[5]  B. Rubin,et al.  Tissue Factor Facilitates Wound Healing in Human Airway Epithelial Cells , 2019, Chest.

[6]  J. McLellan,et al.  Respiratory syncytial virus entry and how to block it , 2019, Nature Reviews Microbiology.

[7]  R. Smyth,et al.  An in vitro transepithelial migration assay to evaluate the role of neutrophils in Respiratory Syncytial Virus (RSV) induced epithelial damage , 2018, Scientific Reports.

[8]  G. Whittaker,et al.  Fusion of Enveloped Viruses in Endosomes , 2016, Traffic.

[9]  M. Shields,et al.  Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials , 2015, Influenza and other respiratory viruses.

[10]  K. Hon,et al.  Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children , 2013, Infection.

[11]  A. Paget-Brown,et al.  Safety of an Alkalinizing Buffer Designed for Inhaled Medications in Humans , 2013, Respiratory Care.

[12]  A. Helenius,et al.  Host Cell Entry of Respiratory Syncytial Virus Involves Macropinocytosis Followed by Proteolytic Activation of the F Protein , 2013, PLoS pathogens.

[13]  A. Helenius Virus entry: What has pH got to do with it? , 2013, Nature Cell Biology.

[14]  B. Resch Burden of respiratory syncytial virus infection in young children. , 2012, World journal of clinical pediatrics.

[15]  B. Rubin,et al.  IL‐13‐induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  N. Roberts,et al.  Small Interfering RNA Profiling Reveals Key Role of Clathrin-Mediated Endocytosis and Early Endosome Formation for Infection by Respiratory Syncytial Virus , 2007, Journal of Virology.

[17]  F. Gisou van der Goot,et al.  Mechanisms of pathogen entry through the endosomal compartments , 2006, Nature Reviews Molecular Cell Biology.

[18]  B. Gaston,et al.  Acid stress in the pathology of asthma. , 2004, The Journal of allergy and clinical immunology.

[19]  L. R. Macfarlane,et al.  Department of pathology , 1961, Journal of the Royal Army Medical Corps.

[20]  Scott H Randell,et al.  Human nasal and tracheo-bronchial respiratory epithelial cell culture. , 2013, Methods in molecular biology.